Published :
Tables : 19
Figures : 31
Category : Healthcare
No. of Pages : 220
Report Code : HC-1069
Apheresis Systems Market Introduction Apheresis Systems Market is envisioned to value over US $ 4 billion by the end of 2027 and record at a CAGR of over 7% during the forecast period of 2020-2027. Apheresis system is very helpful when it comes to collection and separation of blood components that are necessary for donation. Additionally, it also assists in removing or exchanging blood components for the purpose of therapy. The plasma or platelets are separated and collected when the red blood cells are returned back into the bloodstream of the donor. Depending on the blood constituents that undergo centrifugation, there are various types of procedures such as platelets (plateletphersis), plasma (plasmapheresis), lymphocytes (lymphophersis or lymphaphersis), leukocytes (leukaphersis) and red blood cells (erythrophersis). This procedure can also be implemented for therapy where the diseased blood component is removed while the healthy blood component is returned back into the circulation of the patient. Additionally, this procedure can also be used for the purpose of stem cell harvesting. The increasing importance of apheresis systems in blood component separation in therapeutics procedure fuelled the growth of the market. It is commonly used for severe rheumatoid arthritis, Goodpasture syndrome, leukostasis, systemic lupus, and others. It is also used to reduce the risk of the antibody-mediated immune response during organ transplantation. So, it has significant importance in the healthcare setting in lifesaving interventions. It is further supported by the rapid advancement of technologies and led to the rapid evolution of continuous units for simultaneous blood collection and removal. Additionally, recent advancements decreased complications associated and made it more advantageous over the traditional methods. Further, increasing healthcare expenditure by both private and public sectors to incorporate advanced technologies created huge opportunities for the market growth The Asia Pacific account significant share in the global market and created potential opportunities for international players due to increasing government support. It is majorly dominated by domestic manufacturers and expected to remain the same throughout the forecast period. Whereas, developed economies like North America & Europe witnessed strong penetration due to the increasing prevalence and stringent regulatory conditions. US, UK, France, Japan, and Germany account a major share in the global market due to high penetration. Latin America and Rest of World regions witnessed fast growth rate during the forecast period due to increasing adoption. Major market players include TERUMO BCT, INC., Fresenius Kabi, B. Braun Melsungen AG, Asahi Kasei Medical Co., Ltd, Macopharma, Grifolss, Delcon Medical Devices, and others. Apheresis Systems Market Segmentation: By Product Type Standalone Apheresis Systems Portable Apheresis Systems Consumables and Supplies By End User Hospitals Outpatient Centres Blood Banks By Region North America Latin America Europe Asia Pacific Rest of the World Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global Apheresis Systems Market by Product Type, by End User, by Region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Apheresis Systems Market is envisioned to value over US $ 4 billion by the end of 2027 and record at a CAGR of over 7% during the forecast period of 2020-2027.
Apheresis system is very helpful when it comes to collection and separation of blood components that are necessary for donation. Additionally, it also assists in removing or exchanging blood components for the purpose of therapy. The plasma or platelets are separated and collected when the red blood cells are returned back into the bloodstream of the donor. Depending on the blood constituents that undergo centrifugation, there are various types of procedures such as platelets (plateletphersis), plasma (plasmapheresis), lymphocytes (lymphophersis or lymphaphersis), leukocytes (leukaphersis) and red blood cells (erythrophersis). This procedure can also be implemented for therapy where the diseased blood component is removed while the healthy blood component is returned back into the circulation of the patient. Additionally, this procedure can also be used for the purpose of stem cell harvesting.
The increasing importance of apheresis systems in blood component separation in therapeutics procedure fuelled the growth of the market. It is commonly used for severe rheumatoid arthritis, Goodpasture syndrome, leukostasis, systemic lupus, and others. It is also used to reduce the risk of the antibody-mediated immune response during organ transplantation. So, it has significant importance in the healthcare setting in lifesaving interventions. It is further supported by the rapid advancement of technologies and led to the rapid evolution of continuous units for simultaneous blood collection and removal. Additionally, recent advancements decreased complications associated and made it more advantageous over the traditional methods. Further, increasing healthcare expenditure by both private and public sectors to incorporate advanced technologies created huge opportunities for the market growth
The Asia Pacific account significant share in the global market and created potential opportunities for international players due to increasing government support. It is majorly dominated by domestic manufacturers and expected to remain the same throughout the forecast period. Whereas, developed economies like North America & Europe witnessed strong penetration due to the increasing prevalence and stringent regulatory conditions. US, UK, France, Japan, and Germany account a major share in the global market due to high penetration. Latin America and Rest of World regions witnessed fast growth rate during the forecast period due to increasing adoption.
Major market players include TERUMO BCT, INC., Fresenius Kabi, B. Braun Melsungen AG, Asahi Kasei Medical Co., Ltd, Macopharma, Grifolss, Delcon Medical Devices, and others.
Apheresis Systems Market Segmentation:
By Product Type
By End User
By Region
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the global Apheresis Systems Market by Product Type, by End User, by Region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Apheresis Systems Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Apheresis Systems Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Apheresis Systems Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Apheresis Systems Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Apheresis Systems Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Standalone Apheresis Systems 7.2. Portable Apheresis Systems 7.3. Consumables and Supplies 8. Global Apheresis Systems Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Hospitals 8.2. Outpatient Centres 8.3. Blood Banks 9. North America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2020-2027 10. Latin America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2020-2027 11. Europe Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2020-2027 12. Asia Pacific Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Saudi Arabia 13.2.2. UAE 13.2.3. South Africa 13.2.4. Egypt 13.3. Market Size (USD Million) Forecast for MEA 2020-2027 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 14.1. TERUMO BCT, INC. 14.1.1. Company Overview 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2. Fresenius Kabi 14.2.1. Company Overview 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3. B. Braun Melsungen AG, 14.3.1. Company Overview 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4. Asahi Kasei Medical Co., Ltd 14.4.1. Company Overview 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5 Macopharma 14.5.1. Company Overview 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6 Grifolss 14.6.1. Company Overview 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7. Delcon Medical Devices 14.7.1. Company Overview 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 15. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics